Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a 25-hydroxyvitamin D analog, such as a vitamin D-C22 immunogenic molecule or compound. Antibodies produced using...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SAHAKIAN, Niver Panosian CAMPBELL, Bruce A LIAO, Qimu EVANGELISTA, Ramon A LIN, Spencer Hsiang-Hsi FREEMAN, James Vincent |
description | Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a 25-hydroxyvitamin D analog, such as a vitamin D-C22 immunogenic molecule or compound. Antibodies produced using these antigenic molecules, and related antigenic compounds, are also described. In addition, disclosed herein are methods for detecting vitamin D deficiency in a subject, methods for treating a subject suspected of having a vitamin D deficiency, methods for monitoring progression of vitamin D deficiency in a subject, and methods for monitoring treatment of vitamin D deficiency in a subject in need thereof. Also provided are methods and reagents for the detection or quantification of 25-hydroxyvitamin D2 and D3, methods for stabilizing vitamin D analogs, and methods for separating 25 hydroxyvitamin D2 and D3 from vitamin D binding protein in a biological sample. - 77- |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017203779BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017203779BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017203779BB23</originalsourceid><addsrcrecordid>eNrjZLByzCvJTMpPyUwtVijJVzAy1c2oTCnKr6gsyyxJzM3MU3AxUkjMS1FwMQZTpcUgdRmpRan5aTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JN4x1MjA0NzIwNjc3NLJyciYSGUA7TAvDw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof</title><source>esp@cenet</source><creator>SAHAKIAN, Niver Panosian ; CAMPBELL, Bruce A ; LIAO, Qimu ; EVANGELISTA, Ramon A ; LIN, Spencer Hsiang-Hsi ; FREEMAN, James Vincent</creator><creatorcontrib>SAHAKIAN, Niver Panosian ; CAMPBELL, Bruce A ; LIAO, Qimu ; EVANGELISTA, Ramon A ; LIN, Spencer Hsiang-Hsi ; FREEMAN, James Vincent</creatorcontrib><description>Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a 25-hydroxyvitamin D analog, such as a vitamin D-C22 immunogenic molecule or compound. Antibodies produced using these antigenic molecules, and related antigenic compounds, are also described. In addition, disclosed herein are methods for detecting vitamin D deficiency in a subject, methods for treating a subject suspected of having a vitamin D deficiency, methods for monitoring progression of vitamin D deficiency in a subject, and methods for monitoring treatment of vitamin D deficiency in a subject in need thereof. Also provided are methods and reagents for the detection or quantification of 25-hydroxyvitamin D2 and D3, methods for stabilizing vitamin D analogs, and methods for separating 25 hydroxyvitamin D2 and D3 from vitamin D binding protein in a biological sample. - 77-</description><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190801&DB=EPODOC&CC=AU&NR=2017203779B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190801&DB=EPODOC&CC=AU&NR=2017203779B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAHAKIAN, Niver Panosian</creatorcontrib><creatorcontrib>CAMPBELL, Bruce A</creatorcontrib><creatorcontrib>LIAO, Qimu</creatorcontrib><creatorcontrib>EVANGELISTA, Ramon A</creatorcontrib><creatorcontrib>LIN, Spencer Hsiang-Hsi</creatorcontrib><creatorcontrib>FREEMAN, James Vincent</creatorcontrib><title>Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof</title><description>Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a 25-hydroxyvitamin D analog, such as a vitamin D-C22 immunogenic molecule or compound. Antibodies produced using these antigenic molecules, and related antigenic compounds, are also described. In addition, disclosed herein are methods for detecting vitamin D deficiency in a subject, methods for treating a subject suspected of having a vitamin D deficiency, methods for monitoring progression of vitamin D deficiency in a subject, and methods for monitoring treatment of vitamin D deficiency in a subject in need thereof. Also provided are methods and reagents for the detection or quantification of 25-hydroxyvitamin D2 and D3, methods for stabilizing vitamin D analogs, and methods for separating 25 hydroxyvitamin D2 and D3 from vitamin D binding protein in a biological sample. - 77-</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLByzCvJTMpPyUwtVijJVzAy1c2oTCnKr6gsyyxJzM3MU3AxUkjMS1FwMQZTpcUgdRmpRan5aTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JN4x1MjA0NzIwNjc3NLJyciYSGUA7TAvDw</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>SAHAKIAN, Niver Panosian</creator><creator>CAMPBELL, Bruce A</creator><creator>LIAO, Qimu</creator><creator>EVANGELISTA, Ramon A</creator><creator>LIN, Spencer Hsiang-Hsi</creator><creator>FREEMAN, James Vincent</creator><scope>EVB</scope></search><sort><creationdate>20190801</creationdate><title>Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof</title><author>SAHAKIAN, Niver Panosian ; CAMPBELL, Bruce A ; LIAO, Qimu ; EVANGELISTA, Ramon A ; LIN, Spencer Hsiang-Hsi ; FREEMAN, James Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017203779BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SAHAKIAN, Niver Panosian</creatorcontrib><creatorcontrib>CAMPBELL, Bruce A</creatorcontrib><creatorcontrib>LIAO, Qimu</creatorcontrib><creatorcontrib>EVANGELISTA, Ramon A</creatorcontrib><creatorcontrib>LIN, Spencer Hsiang-Hsi</creatorcontrib><creatorcontrib>FREEMAN, James Vincent</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAHAKIAN, Niver Panosian</au><au>CAMPBELL, Bruce A</au><au>LIAO, Qimu</au><au>EVANGELISTA, Ramon A</au><au>LIN, Spencer Hsiang-Hsi</au><au>FREEMAN, James Vincent</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof</title><date>2019-08-01</date><risdate>2019</risdate><abstract>Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a 25-hydroxyvitamin D analog, such as a vitamin D-C22 immunogenic molecule or compound. Antibodies produced using these antigenic molecules, and related antigenic compounds, are also described. In addition, disclosed herein are methods for detecting vitamin D deficiency in a subject, methods for treating a subject suspected of having a vitamin D deficiency, methods for monitoring progression of vitamin D deficiency in a subject, and methods for monitoring treatment of vitamin D deficiency in a subject in need thereof. Also provided are methods and reagents for the detection or quantification of 25-hydroxyvitamin D2 and D3, methods for stabilizing vitamin D analogs, and methods for separating 25 hydroxyvitamin D2 and D3 from vitamin D binding protein in a biological sample. - 77-</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2017203779BB2 |
source | esp@cenet |
subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
title | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A08%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAHAKIAN,%20Niver%20Panosian&rft.date=2019-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017203779BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |